MSM PROTEIN TECHNOLOGIES

MSM Protein Technologies is an early drug development company focused on advancing its own first-in-class, fully human antibodies targeting several GPCRs... MSM was founded in 2005 as an antibody drug discovery company focused on difficult membrane protein targets. Our proprietary fully-integrated technology platform allows for rapid and reliable generation of human therapeutic antibodies using phage display libraries. Recently, the platform was extended to mammalian cell display libraries and immunization approaches. We have successfully completed a dozen projects aimed at generating functional human antibodies to GPCRs, in collaborative projects and for our internal pipeline. The company is seeking partners for de novo discovery as well as to advance our proprietary antibodies for the treatment of oncologic, autoimmune, inflammatory and respiratory diseases into clinical development.

Also known as: MSM, MSM Protein Technologies, Inc.

Primary location: Waltham United States